CD3&CD28磁珠產品信息
背景（Background）
Human T cell Activation/Expansion CD3/CD28 Beads, premium grade DMF Filed are uniform 5.5 μm of magnetic beads coated with an optimized mixture of monoclonal antibodies against the CD3 and CD28. The CD3 antibody is specific for the epsilon chain of human CD3, which is considered to be a subunit of the TCR complex. The CD28 antibody is specific for the human CD28 co-stimulatory molecule, which is the receptor for CD80 (B7-1) and CD86 (B7-2). Both antibodies are mouse anti-human IgGs coupled to the same bead, mimicking in vivo stimulation by APCs.
應用說明（Application）
ActiveMax? Human T cell Activation/Expansion CD3/CD28 Beads, premium grade DMF Filed is intended for the in vitro isolation, stimulation and expansion of purified T cell populations of, for example, CD3+T cells, CD4+ T cells, CD8+ T cells or human PBMC in early preclinical stage.
重構方法（Reconstitution）
See Certificate of Analysis (CoA) for detailed instruction.
存儲（Storage）
The product is shipped at ambient temperature. Upon receipt, store it immediately at -20°C or below for long term storage. This product is stable after storage at: 1 -20°C or below for 5 years in lyophilized state from date of receipt; 2. 2-8°C for 12 months under sterile conditions after reconstitution.
Please avoid repeated freeze-thaw cycles after reconstitution.
內毒素（Endotoxin）
Less than 0.002 EU per μg by the LAL method.
注意事項（Important Note）
This product is for research use only and not intended for therapeutic or in vivo diagnostic use.
制劑（Formulation）
Please contact us for detailed information.
Contact us for customized product form or formulation.
CD3&CD28磁珠用戶評價
關鍵字： CD3&CD28;CD3&CD28磁珠;CD3磁珠;CD28磁珠;百普賽斯;
百普賽斯集團ACROBiosystems Group（股票代碼：301080）是成立于2010年的跨國生物科技公司，是為全球生物醫(yī)藥、健康產業(yè)領域提供關鍵生物試劑產品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團業(yè)務遍布全球，橫跨亞洲、北美洲、歐洲，在中國、美國、瑞士等12個城市設有辦公室、研發(fā)中心及生產基地。目前累計服務客戶超6000家，與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關系。集團旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學等。